middle.news
How 4DMedical’s CT:VQ™ Is Gaining Ground at Stanford Ahead of FDA Approval
8:53am on Tuesday 17th of June, 2025 AEST
•
Healthcare
Read Story
How 4DMedical’s CT:VQ™ Is Gaining Ground at Stanford Ahead of FDA Approval
8:53am on Tuesday 17th of June, 2025 AEST
Key Points
Renewed one-year subscription with Stanford’s 3DQ Lab
Inclusion of CT – VQ™ for research prior to FDA approval
Stanford licenses CT LVAS™ and AI-based IQ-UIP™ alongside CT – VQ™
Contract allows up to 20,000 CT scan analyses annually
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
4Dmedical (ASX:4DX)
OPEN ARTICLE